Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Oestrogen producing enzymes and mammary carcinogenesis: a review.

Subramanian A, Salhab M, Mokbel K.

Breast Cancer Res Treat. 2008 Sep;111(2):191-202. Epub 2007 Oct 13. Review.

PMID:
17934808
2.

Oestrogen-synthesising enzymes and breast cancer.

Kulendran M, Salhab M, Mokbel K.

Anticancer Res. 2009 Apr;29(4):1095-109. Review.

3.

Steroid metabolism in breast cancer.

Foster PA.

Minerva Endocrinol. 2008 Mar;33(1):27-37. Review.

4.

New development in intracrinology of breast carcinoma.

Sasano H, Suzuki T, Nakata T, Moriya T.

Breast Cancer. 2006;13(2):129-36. Review.

5.

Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.

Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T.

J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):455-60.

PMID:
14623544
6.

The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.

Salhab M, Reed MJ, Al Sarakbi W, Jiang WG, Mokbel K.

Breast Cancer Res Treat. 2006 Sep;99(2):155-62. Epub 2006 Mar 16.

PMID:
16541304
7.
8.

Intracrine mechanism of estrogen synthesis in breast cancer.

Suzuki T, Moriya T, Ishida T, Ohuchi N, Sasano H.

Biomed Pharmacother. 2003 Dec;57(10):460-2. Review.

PMID:
14637389
9.

Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.

Pasqualini JR, Chetrite GS.

J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):221-36. Review.

PMID:
15860265
10.

In situ production of estrogens in human breast carcinoma.

Suzuki T, Moriya T, Ishida T, Kimura M, Ohuchi N, Sasano H.

Breast Cancer. 2002;9(4):296-302. Review.

PMID:
12459709
11.

Steroid sulfatase: a new target for the endocrine therapy of breast cancer.

Stanway SJ, Delavault P, Purohit A, Woo LW, Thurieau C, Potter BV, Reed MJ.

Oncologist. 2007 Apr;12(4):370-4. Review.

12.

Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.

Smuc T, Rizner TL.

Chem Biol Interact. 2009 Mar 16;178(1-3):228-33. doi: 10.1016/j.cbi.2008.10.038. Epub 2008 Nov 5.

PMID:
19022235
13.

Aromatase inhibitors: new endocrine treatment of breast cancer.

Brueggemeier RW.

Semin Reprod Med. 2004 Feb;22(1):31-43. Review.

PMID:
15083379
14.

A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.

Foster PA, Chander SK, Newman SP, Woo LW, Sutcliffe OB, Bubert C, Zhou D, Chen S, Potter BV, Reed MJ, Purohit A.

Clin Cancer Res. 2008 Oct 15;14(20):6469-77. doi: 10.1158/1078-0432.CCR-08-1027.

15.

Molecular epidemiology of breast cancer: genetic variation in steroid hormone metabolism.

Kristensen VN, Borresen-Dale AL.

Mutat Res. 2000 Apr;462(2-3):323-33. Review.

PMID:
10767642
16.

Steroid sulfatase inhibitors: promising new therapy for breast cancer.

Sadozai H.

J Pak Med Assoc. 2013 Apr;63(4):509-15. Review.

17.

Aromatase in the context of breast and endometrial cancer. A review.

Jongen VH, Hollema H, Van Der Zee AG, Heineman MJ.

Minerva Endocrinol. 2006 Mar;31(1):47-60. Review.

PMID:
16498363
18.

Quantitative analysis of aromatase, sulfatase and 17beta-HSD(1) mRNA expression in soft tissue metastases of breast cancer.

Irahara N, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.

Cancer Lett. 2006 Nov 8;243(1):23-31. Epub 2006 Mar 23.

PMID:
16556483
19.

Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?

Geisler J, Sasano H, Chen S, Purohit A.

J Steroid Biochem Mol Biol. 2011 May;125(1-2):39-45. doi: 10.1016/j.jsbmb.2011.02.002. Epub 2011 Feb 26. Review.

PMID:
21356310
20.

Sex steroid-producing enzymes in human breast cancer.

Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H.

Endocr Relat Cancer. 2005 Dec;12(4):701-20. Review.

Supplemental Content

Support Center